site stats

Cancer discovery影响因子

WebFirst Published: 27 March 2024. Herein, we report a fully remote clinical trial of an oral anticancer drug, which is the first of its kind in Japan. This framework is a breakthrough … http://lib.smu.edu.cn/article/detail/144

Cell discovery 影响因子几何? - 知乎

WebJan 11, 2024 · The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal is open access and covers the full spectrum of cancer science and medicine, from basic and translational scientific investigations to early- and late-phase clinical trials, epidemiologic studies, and … Web2024年最新影响因子正式揭晓!刚刚,2024年6月28日, Clarivate Analytics(科睿唯安)发布了各大SCI期刊的2024年影响因子。 肿瘤神刊CA仍居榜首,但降幅高达43%,近乎腰斩! 肿瘤神刊+四大医学杂志2024 JIFCA286.… diamond and fischer https://letmycookingtalk.com

Cancer Discovery_影响因子(IF)_中科院分区_SCI期刊投 …

WebApr 3, 2024 · Cancer therapy has advanced significantly in recent years, however, cancer remains a major health problem that requires further discovery and innovation to … Web2024年最新影响因子正式揭晓!刚刚,2024年6月28日, Clarivate Analytics(科睿唯安)发布了各大SCI期刊的2024年影响因子。 肿瘤神刊CA仍居榜首,但降幅高达43%,近乎腰 … WebCancer Discovery: 38.272 Cancer Epidemiology, Biomarkers & Prevention: 4.090 Cancer Immunology Research: 12.020 Cancer Prevention Research: 3.296 Cancer Research: … diamond and fishman oshawa

生物标志物研究杂志-Biomarker Research-首页

Category:生物标志物研究杂志-Biomarker Research-首页

Tags:Cancer discovery影响因子

Cancer discovery影响因子

Nature Cancer

Web总结了一下我见过的爱发molcular cancer组的特点:. 组内科研风气浮躁,天天嘴里一口一个大文章,然后爱攀比文章数量多少,总因子多少,各种张院士李院士互相追捧,一会你发了大文章富贵了,一会儿我分没你高我完 … WebCancer Research Communications is an open access peer-reviewed journal that encompasses the full spectrum of research on cancer. Launched in October 2024, the journal aims to accelerate the pace of discovery and stimulate innovation in cancer science and medicine by providing a venue for rapid open publication of hypotheses, methods, …

Cancer discovery影响因子

Did you know?

WebJul 19, 2024 · Cancer Discovery的 最新影响因子 :39.397。近年来,这本期刊的影响因子正在以较为平稳的速度进行增长。而去年一反常态,竟一下涨了10分,到了40分的边 …

Web《lancet oncology》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《lancet oncol》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《lancet oncol》" 的价值还取决于各种因素的综合分析。 WebApr 10, 2024 · Discover Oncology. Discover Oncology, formerly Hormones and Cancer, is part of the Discover journal series committed to providing a streamlined submission process, rapid review and publication, and a …

Web《生物标志物研究》(Biomarker Research)是一本以Biochemistry, Genetics and Molecular Biology-Molecular Medicine综合研究为特色的国际期刊。该刊由BMC出版商创刊于2013年,刊期1 issue/year。该刊已被国际重要权威数据库SCIE收录。期刊聚焦Biochemistry, Genetics and Molecular Biology-Molecular Medicine领域的重点研究和前沿进展,及时 ... Web至于Nature communications,nature给它的定位是介于pnas和nature之间,在线发表一些重大成果,无纸质刊物,基本全是是开源的,一方面也是走现在期刊开源的一个潮流,现在一年发文量也已经达到了5000篇左右。 …

WebDec 2, 2024 · 1 The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China. Search for other works by this author on: This Site

Web经验分享:血液领域,投了一篇,1周拒稿,原因是既往这个领域已发表了一些文献,还是创新性差了一些,但是推荐改投AACR旗下新创期刊Blood Cancer Discovery,文章质量 … diamond and felt reversiblescuff padsWeb《Cancer Discovery》发布于爱科学网,并永久归类相关SCI期刊导航类别中,本站只是硬性分析 "《CANCER DISCOV》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。" … circle k astor flWeb从e-century给出的pubmedl链接结果来看,洪教授至少已经发表了400余篇论文,其中不少发表在了Nature、Cancer Cell、Cancer Discovery等高分期刊上。 American Journal of Cancer Research杂志的JCR分区:新晋肿瘤学分区Q1区,以往主要以Q2区为主。最新SCI影响因子为5.177分,在244本肿瘤 ... circle k atg pollingWebJan 17, 2024 · 2024年1月《Cancer Discovery》(IF:39.397)的封面是一个“指环”,对应的是肿瘤学界的经典综述“Hallmarks of Cancer”(癌症的特征),其用一套基础理论来 … diamond and forresterhttp://paper.dxy.cn/article/141561 diamond and flair rorschachWebNov 22, 2024 · Cell Discovery :该刊明年影响因子也会迎来可喜的翻倍,从今年的10.8分,筋斗云似的增长至24.5分。且2024年其发文量迎来小幅度增长,可以窥见杂志社影响力日渐成熟,对“低发文量”的依赖程度在减低。 ... 如Translational Lung Cancer Research、Chinese Journal of Cancer Research ... diamond and forrester calculatorWebFeb 27, 2024 · charles c hong. School of Medicine, University of Maryland. Baltimore, United States. Specialty Chief Editor. Cardiovascular and Hematologic Drugs. circle k atg polling application